{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:02:16Z","timestamp":1756166536388,"version":"3.44.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,25]]},"DOI":"10.7759\/cureus.90922","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:31:16Z","timestamp":1756107076000},"source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Hyperfibrinolysis in Oesophageal Adenocarcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Yuhui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Gelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Brais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Besser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fibrinolysis","volume":"41","author":"Fearnley GR","year":"1967","unstructured":"Fearnley GR. Fibrinolysis. Ann R Coll Surg Engl. 1967, 41:51-4.","journal-title":"Ann R Coll Surg Engl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1715795","article-title":"Hyperfibrinolysis in patients with solid malignant neoplasms: a systematic review","volume":"47","author":"Winther-Larsen A","year":"2021","unstructured":"Winther-Larsen A, Sandfeld-Paulsen B, Hvas AM. Hyperfibrinolysis in patients with solid malignant neoplasms: a systematic review. Semin Thromb Hemost. 2021, 47:581-8. 10.1055\/s-0040-1715795","journal-title":"Semin Thromb Hemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13692","article-title":"Acquired hyperfibrinolysis as the presenting sign of metastatic breast cancer: a case report","volume":"25","author":"Lu G","year":"2023","unstructured":"Lu G, Jia L, Yang R, Lv Z, Cui J. Acquired hyperfibrinolysis as the presenting sign of metastatic breast cancer: a case report. Oncol Lett. 2023, 25:106. 10.3892\/ol.2023.13692","journal-title":"Oncol Lett"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102467","article-title":"Hyperfibrinolysis during the treatment of rhabdomyosarcoma","volume":"8","author":"Taylor SR","year":"2024","unstructured":"Taylor SR, Connors JM, Venkataraman V. Hyperfibrinolysis during the treatment of rhabdomyosarcoma. Res Pract Thromb Haemost. 2024, 8:102467. 10.1016\/j.rpth.2024.102467","journal-title":"Res Pract Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.01.045","article-title":"Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"42","author":"Sch\u00f6nborn L","year":"2024","unstructured":"Sch\u00f6nborn L, Pavord S, Chen VM, et al.. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2024, 42:1799-811. 10.1016\/j.vaccine.2024.01.045","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1383545","article-title":"From fibrinolysis to the plasminogen-plasmin system and beyond: a remarkable growth of knowledge, with personal observations on the history of fibrinolysis","volume":"40","author":"Kwaan HC","year":"2014","unstructured":"Kwaan HC. From fibrinolysis to the plasminogen-plasmin system and beyond: a remarkable growth of knowledge, with personal observations on the history of fibrinolysis. Semin Thromb Hemost. 2014, 40:585-91. 10.1055\/s-0034-1383545","journal-title":"Semin Thromb Hemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1887.sp000265","article-title":"Note on the action of sodium chloride in dissolving fibrin","volume":"8","author":"Green JR","year":"1887","unstructured":"Green JR. Note on the action of sodium chloride in dissolving fibrin. J Physiol. 1887, 8:372-7. 10.1113\/jphysiol.1887.sp000265","journal-title":"J Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)86556-3","article-title":"Fibrinolysis following operation","volume":"229","author":"Macfarlane RG","year":"1937","unstructured":"Macfarlane RG. Fibrinolysis following operation. Lancet. 1937, 229:10-2. 10.1016\/S0140-6736(00)86556-3","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.28.6.559","article-title":"A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors","volume":"28","author":"Christensen LR","year":"1945","unstructured":"Christensen LR, Macleod CM. A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors. J Gen Physiol. 1945, 28:559-83. 10.1085\/jgp.28.6.559","journal-title":"J Gen Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102636","article-title":"Studies on a proteolytic enzyme in human plasma. VII. A fatal hemorrhagic state associated with excessive plasma proteolytic activity in a patient undergoing surgery for carcinoma of the head of the pancreas","volume":"31","author":"Ratnoff OD","year":"1952","unstructured":"Ratnoff OD. Studies on a proteolytic enzyme in human plasma. VII. A fatal hemorrhagic state associated with excessive plasma proteolytic activity in a patient undergoing surgery for carcinoma of the head of the pancreas. J Clin Invest. 1952, 31:521-8. 10.1172\/JCI102636","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12275","article-title":"Development and application of global assays of hyper- and hypofibrinolysis","volume":"4","author":"Ilich A","year":"2020","unstructured":"Ilich A, Noubouossie DF, Henderson M, et al.. Development and application of global assays of hyper- and hypofibrinolysis. Res Pract Thromb Haemost. 2020, 4:46-53. 10.1002\/rth2.12275","journal-title":"Res Pract Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF01697545","article-title":"Blood clotting studies with thrombus stressography; a new investigation procedure (Article in German)","volume":"26","author":"Hartert H","year":"1948","unstructured":"Hartert H. Blood clotting studies with thrombus stressography; a new investigation procedure (Article in German). Klin Wochenschr. 1948, 26:577-83. 10.1007\/BF01697545","journal-title":"Klin Wochenschr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00062","article-title":"Viscoelastic methods of blood clotting assessment - a multidisciplinary review","volume":"2","author":"Benes J","year":"2015","unstructured":"Benes J, Zatloukal J, Kletecka J. Viscoelastic methods of blood clotting assessment - a multidisciplinary review. Front Med (Lausanne). 2015, 2:62. 10.3389\/fmed.2015.00062","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63724-y","article-title":"FIBTEM improves the sensitivity of hyperfibrinolysis detection in severe trauma patients: a retrospective study using thromboelastometry","volume":"10","author":"Wang IJ","year":"2020","unstructured":"Wang IJ, Park SW, Bae BK, et al.. FIBTEM improves the sensitivity of hyperfibrinolysis detection in severe trauma patients: a retrospective study using thromboelastometry. Sci Rep. 2020, 10:6980. 10.1038\/s41598-020-63724-y","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4266\/acc.2018.00199","article-title":"Usefulness of rotational thromboelastometry as a mortality predictor of hyperfibrinolysis in patients with severe trauma","volume":"33","author":"Kim JS","year":"2018","unstructured":"Kim JS, Wang IJ, Yeom SR, et al.. Usefulness of rotational thromboelastometry as a mortality predictor of hyperfibrinolysis in patients with severe trauma. Acute Crit Care. 2018, 33:162-9. 10.4266\/acc.2018.00199","journal-title":"Acute Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev K","year":"2016","unstructured":"Kolev K, Longstaff C. Bleeding related to disturbed fibrinolysis. Br J Haematol. 2016, 175:12-23. 10.1111\/bjh.14255","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi M","year":"1999","unstructured":"Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999, 341:586-92. 10.1056\/NEJM199908193410807","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman T","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010, 116:878-85. 10.1182\/blood-2010-02-261891","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688495","article-title":"Fibrin and fibrinolysis in cancer","volume":"45","author":"Kwaan HC","year":"2019","unstructured":"Kwaan HC, Lindholm PF. Fibrin and fibrinolysis in cancer. Semin Thromb Hemost. 2019, 45:413-22. 10.1055\/s-0039-1688495","journal-title":"Semin Thromb Hemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.06.003","article-title":"Targeting uPA\/uPAR in prostate cancer","volume":"33","author":"Li Y","year":"2007","unstructured":"Li Y, Cozzi PJ. Targeting uPA\/uPAR in prostate cancer. Cancer Treat Rev. 2007, 33:521-7. 10.1016\/j.ctrv.2007.06.003","journal-title":"Cancer Treat Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164097","article-title":"Experimental and clinical evidence supports the use of urokinase plasminogen activation system components as clinically relevant biomarkers in gastroesophageal adenocarcinoma","volume":"13","author":"Tincknell G","year":"2021","unstructured":"Tincknell G, Piper AK, Aghmesheh M, Becker T, Vine KL, Brungs D, Ranson M. Experimental and clinical evidence supports the use of urokinase plasminogen activation system components as clinically relevant biomarkers in gastroesophageal adenocarcinoma. Cancers (Basel). 2021, 13:10.3390\/cancers13164097","journal-title":"Cancers (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15485","article-title":"The urokinase plasminogen activation system in gastroesophageal cancer: a systematic review and meta-analysis","volume":"8","author":"Brungs D","year":"2017","unstructured":"Brungs D, Chen J, Aghmesheh M, Vine KL, Becker TM, Carolan MG, Ranson M. The urokinase plasminogen activation system in gastroesophageal cancer: a systematic review and meta-analysis. Oncotarget. 2017, 8:23099-109. 10.18632\/oncotarget.15485","journal-title":"Oncotarget"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/ijnm.IJNM_195_20","article-title":"Paraneoplastic hyperfibrinolysis: detection of occult prostate cancer with 18F-fluorodeoxyglucose positron emission tomography-computed tomography","volume":"36","author":"Sharma P","year":"2021","unstructured":"Sharma P. Paraneoplastic hyperfibrinolysis: detection of occult prostate cancer with 18F-fluorodeoxyglucose positron emission tomography-computed tomography. Indian J Nucl Med. 2021, 36:203-4. 10.4103\/ijnm.IJNM_195_20","journal-title":"Indian J Nucl Med"},{"key":"ref24","unstructured":"Survival for oesophageal cancer. (2023). Accessed. August 18, 2025: https:\/\/www.cancerresearchuk.org\/about-cancer\/oesophageal-cancer\/survival."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348914-paraneoplastic-hyperfibrinolysis-in-oesophageal-adenocarcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:31:17Z","timestamp":1756107077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348914-paraneoplastic-hyperfibrinolysis-in-oesophageal-adenocarcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.90922","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}